Abstract:We innovatively used CJ-3DP technology to prepare colorful cartoon levetiracetam paediatric preparations with admirable appearances and immediate release characteristics for improved compliance.In this article, exhaustive research was conducted to optimize the drug formulations, and the applicability of the formulation to scale-up the production was considered. Compared with ethanol, isopropanol, as an important basic solvent in printing ink, has stronger prescription tolerance in hot-bubble printing. This is the first time isopropanol is investigated as the basic solvent for CJ-3DP and has achieved excellent printing effect.Through the optimization of formulation and tablet structure, the 3D printed tablets had a admirable appearance and a lower surface roughness, all of which were notably improved compared with the properties of the first 3D printed drug (Spritam®).This study proves that the dispersion of tablets can be further accelerated by adjusting the internal spatial structure of the model, and the flexible adjustment of drug strengths can be achieved by establishing a dosage model to realize personalized administration.3D printing is a promising technology used in the fabrication of complex oral dosage delivery pharmaceuticals. This study first reports an innovative color jet 3D printing (CJ-3DP) technology to produce colorful cartoon levetiracetam paediatric preparations with high accuracy and reproducibility. For this study, the ideal printing ink consisted of 40% (v/v) isopropanol aqueous solution containing 0.05% (w/w) polyvinylpyrrolidone and 4% (w/w) glycerin, which was satisfied with scale-up of the production. The external and internal spatial structures of the tablets were designed to control the appearance and release, and cartoon tablets with admirable appearances and immediate release characteristics were printed. The dosage model showed a good linear relationship between the model volume and the tablet strength (r > 0.999), which proved the potential of personalized administration. The surface roughness indicated that the appearance of the CJ-3DP tablets was significantly better than the first listed 3D printed drug (Spritam®). Moreover, the scanning electron microscopy and porosity results further showed that the tablets have a structure of loose interior and tight exterior, which could ensure good mechanical properties and rapid dispersion characteristics simultaneously. In conclusion, the innovative CJ-3DP technology can be used to fabricate personalized paediatric preparations for improved compliance. Due to the stable formulation and fabrication process, this technology has the potential in scale-up production.<ol class="links-for-figure"><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S1818087621000167-fx1_lrg.jpg">Download : Download high-res image (256KB)</a></li><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S1818087621000167-fx1.jpg">Download : Download full-size image</a></li></ol>

Innovative color jet 3D printing of levetiracetam personalized paediatric preparations

Three-Dimensional Electrohydrodynamic Printing and Spinning of Flexible Composite Structures for Oral Multidrug Forms

Quality of FDM 3D Printed Medicines for Pediatrics: Considerations for Formulation Development, Filament Extrusion, Printing Process and Printer Design

The Exploration of Ink Formulations in Binder Jet 3D Printing Drugs

Semisolid Extrusion 3D Printing of Propranolol Hydrochloride Gummy Chewable Tablets: an Innovative Approach to Prepare Personalized Medicine for Pediatrics

3D screen printing technology enables fabrication of oral drug dosage forms with freely tailorable release profiles

The potential of three-dimensional printing for pediatric oral solid dosage forms

The Effects of Solid Particle Containing Inks on the Printing Quality of Porous Pharmaceutical Structures Fabricated by 3D Semi-Solid Extrusion Printing.

Enabling high-fidelity personalised pharmaceutical tablets through multimaterial inkjet 3D printing with a water-soluble excipient

Water-based 3D inkjet printing of an oral pharmaceutical dosage form

Structure-Based Gastro-Retentive and Controlled-Release Drug Delivery with Novel 3D Printing

Feasibility of developing hospital preparation by semisolid extrusion 3D printing: personalized amlodipine besylate chewable tablets

[Preparation and in Vitro Evaluation of FDM 3D Printed Theophylline Tablets with Personalized Dosage].

Dose-independent drug release from 3D printed oral medicines for patient-specific dosing to improve therapy safety

Extrusion 3D Printing of Paracetamol Tablets from a Single Formulation with Tunable Release Profiles Through Control of Tablet Geometry

Application of 3D printing technology for the development of dose adjustable geriatric and pediatric formulation of celecoxib

Pilot-scale binder jet 3D printing of sustained release solid dosage forms

Novel 3D Printed Modular Tablets Containing Multiple Anti-Viral Drugs: a Case of High Precision Drop-on-Demand Drug Deposition

3D printing of tablets using inkjet with UV photoinitiation

Fabrication of 3D printed mutable drug delivery devices: a comparative study of volumetric and digital light processing printing

In Vitro Profile of Hydrocortisone Release from Three-Dimensionally Printed Paediatric Mini-Tablets